{"date":"2025-07-15","count":16,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6892-2025-07-15-2247-1czveow","company_id":"6892","company":"台寶生醫","market":"興櫃","industry":"生技醫療","date":"2025-07-15","time":"22:47:12","subject":"本公司依「公開發行公司資金貸與及背書保證處理準則」第二十五條第一項第四款規定公告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台寶生醫（6892），2025-07-15 22:47，「本公司依「公開發行公司資金貸與及背書保證處理準則」第二十五條第一項第四款規定公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8436-2025-07-15-2042-1eynlwt","company_id":"8436","company":"大江","market":"上櫃","industry":"生技醫療","date":"2025-07-15","time":"20:42:33","subject":"代重要子公司大江生醫生物技術(上海)有限公司公告資金貸與人民幣壹億元予TCI Biotech USA LLC一案","clause":"第23款","fact_date":"2025-07-15","cite_as":"公開資訊觀測站重大訊息：大江（8436），2025-07-15 20:42，「代重要子公司大江生醫生物技術(上海)有限公司公告資金貸與人民幣壹億元予TCI Biotech USA LLC一案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7827-2025-07-15-1803-5kw2aq","company_id":"7827","company":"漢康-KY創","market":"上市","industry":"生技醫療","date":"2025-07-15","time":"18:03:46","subject":"本公司董事會決議變更114年第一次股東臨時會召開時間及地點案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢康-KY創（7827），2025-07-15 18:03，「本公司董事會決議變更114年第一次股東臨時會召開時間及地點案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4133-2025-07-15-1737-m71431","company_id":"4133","company":"亞諾法","market":"上市","industry":"生技醫療","date":"2025-07-15","time":"17:37:26","subject":"本公司受邀參加凱基證券舉辦之線上法人說明會","clause":"第12款","fact_date":"2025-07-17","cite_as":"公開資訊觀測站重大訊息：亞諾法（4133），2025-07-15 17:37，「本公司受邀參加凱基證券舉辦之線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2025-07-15-1725-1sv4lzk","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2025-07-15","time":"17:25:00","subject":"公告本公司114年6月份自結應收帳款餘額及回收情形","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2025-07-15 17:25，「公告本公司114年6月份自結應收帳款餘額及回收情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7595-2025-07-15-1722-bsfxdj","company_id":"7595","company":"世基生醫","market":"興櫃","industry":"生技醫療","date":"2025-07-15","time":"17:22:57","subject":"公告本公司會計主管異動案","clause":"第11款","fact_date":"2025-07-15","cite_as":"公開資訊觀測站重大訊息：世基生醫（7595），2025-07-15 17:22，「公告本公司會計主管異動案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6734-2025-07-15-1717-jyuu2y","company_id":"6734","company":"安盛生","market":"興櫃","industry":"生技醫療","date":"2025-07-15","time":"17:17:54","subject":"更正:公告本公司訂定現金增資發行新股認股基準日等相關事宜","clause":"第9款","fact_date":"2025-07-15","cite_as":"公開資訊觀測站重大訊息：安盛生（6734），2025-07-15 17:17，「更正:公告本公司訂定現金增資發行新股認股基準日等相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2025-07-15-1658-1v159oa","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2025-07-15","time":"16:58:37","subject":"公告本公司收到委任律師提供之智慧財產及商業法院調解筆錄","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2025-07-15 16:58，「公告本公司收到委任律師提供之智慧財產及商業法院調解筆錄」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4732-2025-07-15-1604-2k4xpw","company_id":"4732","company":"彥臣","market":"興櫃","industry":"生技醫療","date":"2025-07-15","time":"16:04:42","subject":"代子公司御華生醫公告自主研發新藥NBM-BMX已於114/6/30向美國食品藥物管理局(FDA)提出「轉移性葡萄膜黑色素瘤」之二期人體臨床試驗申請","clause":"第8款","fact_date":"2025-07-15","cite_as":"公開資訊觀測站重大訊息：彥臣（4732），2025-07-15 16:04，「代子公司御華生醫公告自主研發新藥NBM-BMX已於114/6/30向美國食品藥物管理局(FDA)提出「轉移性葡萄膜黑色素」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6734-2025-07-15-1604-lwss1b","company_id":"6734","company":"安盛生","market":"興櫃","industry":"生技醫療","date":"2025-07-15","time":"16:04:24","subject":"公告本公司訂定現金增資發行新股認股基準日等相關事宜","clause":"第9款","fact_date":"2025-07-15","cite_as":"公開資訊觀測站重大訊息：安盛生（6734），2025-07-15 16:04，「公告本公司訂定現金增資發行新股認股基準日等相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6496-2025-07-15-1557-1roellr","company_id":"6496","company":"科懋","market":"上櫃","industry":"生技醫療","date":"2025-07-15","time":"15:57:51","subject":"公告本公司董事辭任","clause":"第6款","fact_date":"2025-07-15","cite_as":"公開資訊觀測站重大訊息：科懋（6496），2025-07-15 15:57，「公告本公司董事辭任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6999-2025-07-15-1545-1qybse2","company_id":"6999","company":"瀚醫生技","market":"興櫃","industry":"生技醫療","date":"2025-07-15","time":"15:45:23","subject":"公告本公司董事會授權董事長訂定除權暨增資基準日相關事宜","clause":"第44款","fact_date":"2025-07-15","cite_as":"公開資訊觀測站重大訊息：瀚醫生技（6999），2025-07-15 15:45，「公告本公司董事會授權董事長訂定除權暨增資基準日相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4147-2025-07-15-1457-1djpca5","company_id":"4147","company":"中裕","market":"上櫃","industry":"生技醫療","date":"2025-07-15","time":"14:57:49","subject":"本公司受邀參加臺灣生技產業高峰論壇","clause":"第12款","fact_date":"2025-07-24","cite_as":"公開資訊觀測站重大訊息：中裕（4147），2025-07-15 14:57，「本公司受邀參加臺灣生技產業高峰論壇」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7729-2025-07-15-1350-1p5h1m5","company_id":"7729","company":"仲恩生醫","market":"興櫃","industry":"生技醫療","date":"2025-07-15","time":"13:50:55","subject":"公告本公司召開法人說明會相關資訊","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仲恩生醫（7729），2025-07-15 13:50，「公告本公司召開法人說明會相關資訊」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6499-2025-07-15-1334-1nsksc0","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2025-07-15","time":"13:34:42","subject":"本公司有價證券近期多次達公布注意交易資訊標準，故公告相關訊息，以利投資人區別暸解","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益安（6499），2025-07-15 13:34，「本公司有價證券近期多次達公布注意交易資訊標準，故公告相關訊息，以利投資人區別暸解」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6976-2025-07-15-1119-csrv9u","company_id":"6976","company":"育世博-KY","market":"興櫃","industry":"生技醫療","date":"2025-07-15","time":"11:19:39","subject":"因應主管機關要求發布重大訊息，澄清媒體報導","clause":"第26款","fact_date":"2025-07-15","cite_as":"公開資訊觀測站重大訊息：育世博-KY（6976），2025-07-15 11:19，「因應主管機關要求發布重大訊息，澄清媒體報導」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}